123 related articles for article (PubMed ID: 29025677)
1. Degradation of glutamate-based organogels for biodegradable implants: In vitro study and in vivo observation.
Hu B; Wang W; Wang Y; Yang Y; Xu L; Li S
Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():80-90. PubMed ID: 29025677
[TBL] [Abstract][Full Text] [Related]
2. Studies on the in vitro and in vivo degradation behavior of amino acid derivative-based organogels.
Li Z; Cao J; Hu B; Li H; Liu H; Han F; Liu Z; Tong C; Li S
Drug Dev Ind Pharm; 2016 Nov; 42(11):1732-41. PubMed ID: 27018332
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of 12-HSA-based organogels as injectable implants for the controlled delivery of hydrophilic and lipophilic therapeutic agents.
Esposito CL; Tardif V; Sarrazin M; Kirilov P; Roullin VG
Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():110999. PubMed ID: 32993979
[TBL] [Abstract][Full Text] [Related]
4. Self-assembled drug delivery system based on low-molecular-weight bis-amide organogelator: synthesis, properties and in vivo evaluation.
Li Z; Cao J; Li H; Liu H; Han F; Liu Z; Tong C; Li S
Drug Deliv; 2016 Oct; 23(8):3168-3178. PubMed ID: 26912188
[TBL] [Abstract][Full Text] [Related]
5. Lipase is essential for the study of in vitro release kinetics from organogels.
Dufresne MH; Marouf E; Kränzlin Y; Gauthier MA; Leroux JC
Mol Pharm; 2012 Jun; 9(6):1803-11. PubMed ID: 22510056
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing the erosion rate and the drug release kinetics from organogels designed as matrices for oral controlled release of a hydrophobic drug.
Pereira Camelo SR; Franceschi S; Perez E; Girod Fullana S; Ré MI
Drug Dev Ind Pharm; 2016; 42(6):985-97. PubMed ID: 26548427
[TBL] [Abstract][Full Text] [Related]
7. Organogels based on amino acid derivatives and their optimization for drug release using response surface methodology.
Hu B; Yan H; Sun Y; Chen X; Sun Y; Li S; Jing Y; Li H
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):266-275. PubMed ID: 31851842
[TBL] [Abstract][Full Text] [Related]
8. Improved initial burst of estradiol organogel as long-term in situ drug delivery implant: formulation, in vitro and in vivo characterization.
Yang Y; Xu L; Gao Y; Wang Q; Che X; Li S
Drug Dev Ind Pharm; 2012 May; 38(5):550-6. PubMed ID: 22420863
[TBL] [Abstract][Full Text] [Related]
9. Systematic modifications of amino acid-based organogelators for the investigation of structure-property correlations in drug delivery system.
Hu B; Sun W; Li H; Sui H; Li S
Int J Pharm; 2018 Aug; 547(1-2):637-647. PubMed ID: 29933060
[TBL] [Abstract][Full Text] [Related]
10. Organogels, promising drug delivery systems: an update of state-of-the-art and recent applications.
Esposito CL; Kirilov P; Roullin VG
J Control Release; 2018 Feb; 271():1-20. PubMed ID: 29269143
[TBL] [Abstract][Full Text] [Related]
11. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
Jhawat V; Gupta S; Saini V
Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
[TBL] [Abstract][Full Text] [Related]
12. Parenteral thermo-sensitive organogel for schizophrenia therapy, in vitro and in vivo evaluation.
Wang D; Zhao J; Liu X; Sun F; Zhou Y; Teng L; Li Y
Eur J Pharm Sci; 2014 Aug; 60():40-8. PubMed ID: 24815944
[TBL] [Abstract][Full Text] [Related]
13. Organogels in drug delivery.
Murdan S
Expert Opin Drug Deliv; 2005 May; 2(3):489-505. PubMed ID: 16296770
[TBL] [Abstract][Full Text] [Related]
14. Application of Solvent Parameters for Predicting Organogel Formation.
Hu B; Sun W; Yang B; Li H; Zhou L; Li S
AAPS PharmSciTech; 2018 Jul; 19(5):2288-2300. PubMed ID: 29845502
[TBL] [Abstract][Full Text] [Related]
15. Olive oil/policosanol organogels for nutraceutical and drug delivery purposes.
Lupi FR; Gabriele D; Baldino N; Mijovic P; Parisi OI; Puoci F
Food Funct; 2013 Oct; 4(10):1512-20. PubMed ID: 24056806
[TBL] [Abstract][Full Text] [Related]
16. Effect of the monostearate/monopalmitate ratio on the oral release of active agents from monoacylglycerol organogels.
Lupi FR; Mancina V; Baldino N; Parisi OI; Scrivano L; Gabriele D
Food Funct; 2018 Jun; 9(6):3278-3290. PubMed ID: 29789827
[TBL] [Abstract][Full Text] [Related]
17. Characterization of organogel as a novel oral controlled release formulation for lipophilic compounds.
Iwanaga K; Sumizawa T; Miyazaki M; Kakemi M
Int J Pharm; 2010 Mar; 388(1-2):123-8. PubMed ID: 20045041
[TBL] [Abstract][Full Text] [Related]
18. Organogels and their use in drug delivery--a review.
Vintiloiu A; Leroux JC
J Control Release; 2008 Feb; 125(3):179-92. PubMed ID: 18082283
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of sorbitan monostearate and sesame oil-based organogels for topical delivery of antimicrobials.
Singh VK; Pramanik K; Ray SS; Pal K
AAPS PharmSciTech; 2015 Apr; 16(2):293-305. PubMed ID: 25277240
[TBL] [Abstract][Full Text] [Related]
20. Combined effect of shearing and cooling rate on the rheology of organogels developed by selected gelators.
De la Peña-Gil A; Álvarez-Mitre FM; González-Chávez MM; Charó-Alonso MA; Toro-Vazquez JF
Food Res Int; 2017 Mar; 93():52-65. PubMed ID: 28290280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
